Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Subendothelial collagen fiber refers to the collagen-based fibrillar structures in the subendothelial connective tissue of blood vessels, primarily exposed to blood when the endothelial barrier is breached[1][4][7]. Collagen fibers in this context are composed mainly of fibrillar collagens (primarily type I and III, with type IV present in the basement membrane)[1][4][5]. They serve as structural elements conferring mechanical stability to the vessel wall and as a critical initiator of hemostasis, providing a surface for platelet adhesion and activation following vascular injury[6][7]. This platelet-collagen interaction, mediated through von Willebrand factor (vWF) and specific platelet receptors (like GPVI), is the principal mechanism by which the subendothelial matrix translates vessel damage into a thrombogenic response[6][7][9]. Although pivotal in vascular disease and hemostasis, "subendothelial collagen fiber" is not itself a receptor, enzyme, or canonical molecular drug target, but rather a structural matrix component whose exposure or modification has profound pathophysiological consequences. Note: "Subendothelial collagen fiber" is not a precisely defined drug target or receptor; it refers to a class of macromolecular structures (collagen fibers) present in a specific anatomic location (subendothelium). Thus, its classification as a "target" is not standard, and most drugs interact with cellular mediators or receptors (e.g., GPVI, vWF) that mediate platelet-collagen interactions, not with collagen fibers directly[6][9]. Therefore, "is_incorrect" is true for use as a canonical drug target.
not directly druggable; involved in platelet activation via interaction with vWF and platelet receptors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen fiber (subendothelial).